Next Gen Digital Diagnostic Platform to Detect Multiple Pathogens within 5 Minutes at Gene Level
|
By HospiMedica International staff writers Posted on 30 Jun 2023 |
|
An advanced digital diagnostic platform with the capability to detect multiple pathogens in five minutes at the molecular gene level and priced significantly lower than current molecular tests is all set to disrupt the PCR market.
Check4 by IdentifySensors Biologics (Cleveland, OH, USA) is a next-generation digital diagnostic platform that has been developed to detect the genetic material of a wide range of pathogens for over-the-counter and point-of-care use. The Check4 testing platform comprises two components: a reusable Bluetooth reader roughly the size of a mobile phone, and disposable test cartridges that connect to the reader. Each test sample can simultaneously detect up to three different pathogens. Digital graphene sensors within the cartridges target conserved regions of the genome, thereby ensuring high sensitivity and specificity without the need for enzymatic amplification or reagents.
The sensors in the disposable cartridges can be customized to identify a broad range of pathogens that display similar symptoms. Multiplex tests are in development for respiratory pathogens (COVID, RSV, and influenza), gastrointestinal pathogens (Norovirus, Rotavirus, and Adenovirus), and sexually transmitted pathogens (HIV, Hepatitis, Chlamydia, Gonorrhea, and Herpes). Other tests under development include those for SEPSIS, MRSA, Lyme disease, and tropical pathogens such as Zika, Dengue, Yellow Fever, and West Nile virus. Previous research indicates that Check4 can potentially diagnose infections like COVID, RSV, and influenza even before patients exhibit symptoms. IdentifySensors has commenced testing this novel diagnostic device in anticipation of FDA submissions. Clinical studies for the Check4 diagnostic device are slated for this year as part of an extensive testing platform designed to be adapted for detecting a broad range of additional pathogens in the coming years.
"In preliminary studies we have seen encouraging results of this new technology," said Greg Hummer M.D., IdentifySensors co-founder and CEO. "We are excited to test these devices and move forward with additional targets that detect a wide range of infections."
Related Links:
IdentifySensors Biologics
Latest Point of Care News
- Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices
- Rapid Onsite Testing Reduces Emergency Department Transfers in Long-Term Care
- New Brain Ultrasound Platform Enables Bedside Postoperative Imaging
- Handheld Ultrasound Expands Point-of-Care Imaging Access in Brazil
- AI Dermatology Platform Targets Early Detection of Non-Melanoma Skin Cancer
- Handheld AI Device for Point-of-Care Skin Lesion Assessment Receives CE Mark
- Portable Immunoassay System Advances Toward Point-of-Care Biomarker Testing
- Portable MRI System Accelerates Emergency Brain Imaging and Triage
- Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
- Portable MRI System Gains CE Mark for Point-of-Care Brain Imaging
- AI-Enabled Platform Supports Clinical Decision-Making in Melanoma Detection
Channels
Artificial Intelligence
view channel
AI Digital Twin Platform Supports Personalized Cancer Treatment
Oncology teams face persistent challenges in tailoring treatment plans as tumors evolve and responses vary across patients. Static snapshots from imaging or genomics offer limited guidance for complex... Read more
Study Reveals Persistent Race and Gender Bias in Medical AI Models
Hospitals are turning to artificial intelligence (AI) to draft clinical materials and support decision-making, yet algorithmic bias can entrench inequities in care. When generated content reflects racial... Read more
New Study Highlights Benefits and Risks of AI Explanations in Clinical Diagnosis
Explainable artificial intelligence is increasingly used in tools that help clinicians and patients assess skin disease, but its explanations can influence decisions and contribute to overreliance or error.... Read more
Critical Care
view channel
Smart Patch Could Detect Fentanyl and Deliver Automatic Overdose Aid
Fentanyl overdoses can cause rapid respiratory depression and death, often occurring when no responder is present. Current reversal depends on timely administration of naloxone, which is not always available... Read more
AI Wearable Enables Continuous Noninvasive Arterial Blood Pressure Monitoring
Continuous, beat-to-beat blood pressure monitoring in intensive care units often relies on arterial lines, which are invasive and carry risks such as bleeding, clotting, and infection. Intermittent cuff... Read more
Inflatable Device Streamlines Repositioning of Proned Ventilated Patients
Prone ventilation is a key intervention for severe respiratory failure and acute respiratory distress syndrome, but repositioning sedated, ventilated patients is labor-intensive and time-consuming.... Read more
Intensive Blood Pressure Management Reduces Recurrent Stroke After Intracerebral Hemorrhage
Intracerebral hemorrhage (ICH), or bleeding within brain tissue, carries high early mortality and leaves survivors at substantial risk of recurrent stroke. Secondary prevention remains challenging because... Read moreSurgical Techniques
view channel
New Radiofrequency Wand Enhances Access and Tissue Targeting in Hip Surgery
Identifying the source of hip pain can be challenging, and arthroscopic repair is often technically demanding. Surgeons may struggle to reach targeted tissues in constrained joint spaces, while fixed-angle... Read more
Hybrid Bioprinting Platform Creates Capillary-Scale Vascular Networks
More than 100,000 people in the United States await organ transplants, and a new candidate is added every 10 minutes. Even when surgery succeeds, recipients face lifelong immunosuppression, infection risk... Read more
New Robotic Bronchoscopy Software Enables Flexible Imaging for Complex Lung Biopsies
Lung cancer remains the leading cause of cancer death worldwide, and early diagnosis often depends on accurately sampling small peripheral pulmonary lesions. Conventional bronchoscopy can be affected by... Read more
Patient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Medical Imaging
view channel
Imaging Biomarkers Aim to Personalize Treatment for Post-Stroke Bladder Dysfunction
Post-stroke lower urinary tract dysfunction, including urinary incontinence, affects many stroke survivors and can persist long after the acute event. These symptoms undermine independence, burden caregivers,... Read more
New AI Method Improves CT Images by Reducing Metal Artifacts
Computed tomography (CT) is essential for diagnosis and image‑guided treatment, yet high‑density metals such as dental fillings, orthopedic hardware, and stents create beam hardening and photon starvation... Read more
Health IT
view channel
Digital Symptom Monitoring Supports More Personalized Breast Cancer Care
Metastatic breast cancer, in which tumors spread to other organs, is incurable but increasingly managed with modern systemic therapies. As more treatments shift from hospital infusions to oral or at-home... Read more
Short Digital Training Program Improves Motor Function in Parkinson’s Disease
Parkinson's disease causes motor symptoms that interfere with movement and daily activities. Drug treatment is standard care, yet additional approaches are needed to target motor control.... Read more
Business
view channel
Teledyne to Acquire Varex Imaging in $1.1 Billion Deal
Teledyne Technologies and Varex Imaging Corporation announced a definitive agreement on August 10, 2026, under which Teledyne will acquire all outstanding common shares of Varex for USD 18.... Read more
